trial · primary record
Amivantamab
Squamous Cell Carcinoma of Head and Neck
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 287 |
| Primary completion | 2033-07-28 |
| Primary endpoint | Cohorts 1, 2, 3B, 4 and 5: Objective Response Rate |
| Registry ID | NCT06385080 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:53.486Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06385080
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Amivantamab · compound